Global Differences in Characteristics, Precipitants, and Initial Management of Patients Presenting With Acute Heart Failure
-
- Gerasimos Filippatos
- University of Cyprus School of Medicine, Cyprus, Greece
-
- Christiane E. Angermann
- Comprehensive Heart Failure Center, University Hospital, Department of Medicine I–Cardiology, University of Würzburg, Würzburg, Germany
-
- John G. F. Cleland
- Robertson Centre for Biostatistics and Clinical Trials, Institute of Health & Well-Being, University of Glasgow, Glasgow, United Kingdom
-
- Carolyn S. P. Lam
- National Heart Centre Singapore, Singapore
-
- Ulf Dahlström
- Department of Cardiology, Department of Medical and Health Sciences, Linkoping University, Linkoping, Sweden
-
- Kenneth Dickstein
- Stavanger University Hospital, University of Bergen, Bergen, Norway
-
- Georg Ertl
- Comprehensive Heart Failure Center, University Hospital, Department of Medicine I–Cardiology, University of Würzburg, Würzburg, Germany
-
- Mahmoud Hassanein
- Department of Cardiology, Faculty of Medicine, Alexandria University, Alexandria, Egypt
-
- Kimberly W. Hart
- Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee
-
- Christopher J. Lindsell
- Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee
-
- Sergio V. Perrone
- El Cruce Hospital by Florencio Varela, Lezica Cardiovascular Institute, Sanctuary of the Trinidad Miter, Buenos Aires, Argentina
-
- Tadhg Guerin
- Novartis Ireland Ltd, Dublin, Ireland
-
- Mathieu Ghadanfar
- Novartis Pharma AG, Basel, Switzerland
-
- Anja Schweizer
- Novartis Pharma AG, Basel, Switzerland
-
- Achim Obergfell
- Novartis Pharma AG, Basel, Switzerland
-
- Sean P. Collins
- Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, Tennessee
収録刊行物
-
- JAMA Cardiology
-
JAMA Cardiology 5 (4), 401-, 2020-04-01
American Medical Association (AMA)